Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tepezza. Always confirm against the full prescribing information.
100 interactions
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Teprotumumab.
Level 2 evidence
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Teprotumumab.
Level 2 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Teprotumumab.
Level 2 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Teprotumumab.
Level 2 evidence
Bexagliflozin
The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Teprotumumab.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Teprotumumab.
Level 2 evidence
Bromocriptine
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Teprotumumab.
Level 2 evidence
Canagliflozin
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Teprotumumab.
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Teprotumumab.
Level 2 evidence
Dapagliflozin
The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Teprotumumab.
Level 2 evidence
Aducanumab
The risk or severity of adverse effects can be increased when Teprotumumab is combined with Aducanumab.
Level 2 evidence
Enter your NPI to unlock 62 major interactions for Tepezza
Tepezza (Teprotumumab) has 425 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Tepezza (Teprotumumab) has 220 major, 85 moderate, and 120 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tepezza. Always confirm against the full prescribing information.